With the impacts of gun violence felt across families, communities, and the country, it is not only a public health crisis but a women’s health issue.
The 2022 Women’s Health Policy Agenda outlines policy priorities across five key areas—public health, research and clinical trials, lifespan issues, coverage and access, and the biomedical research workforce.
Updated January 18, 2022. The Society for Women’s Health Research (SWHR) has joined the Society for Maternal-Fetal Medicine (SMFM) and […]
At the September Policy Advisory Council meeting, leadership from the Food and Drug Administration (FDA) and NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) discussed how they are working to advance the nation’s health with an emphasis on women’s health.
The national opioid epidemic was already raging before COVID-19 hit the United States. During the pandemic, the situation severely worsened, including for those who are pregnant.
The Department of Health and Human Services (HHS) Office on Women’s Health is pleased to offer the following upcoming webinar in the ongoing COVID-19 Vaccines and Women series.
The NIH Office of Research on Women's Health will host “Analysis and Action: Applications of Intersectionality in COVID-19,” the second lecture in the “Diverse Voices: COVID-19, Intersectionality, and the Health of Women” speaker series.
TEAM Vaccinate’s Conquer Covid-19 Conference will take place on July 21-22, 2021, both virtually and in-person in Washington, D.C.
Disaggregating clinical trial data by sex and gender could ultimately help us understand and respond to disparities in vaccination more quickly.